Parkinson's Disease Trial, Recruiting (NCT06856941)

Parkinson's Disease Trial, Recruiting NCT06856941 Sponsor: Universidade Federal de Pernambuco Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06856941 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Parkinson's disease by a neurologist
People who have been taking dopaminergic medication (a common type of Parkinson's medication) regularly for at least three months
People who are 40 years of age or older
People whose Parkinson's symptoms fall within stages 1 to 4 on a standard scale used to measure how advanced the condition is (called the modified Hoehn and Yahr scale)

Who may not be able to join:

People who have other neurological conditions, low blood pressure when standing, balance-related ear problems, bone or muscle conditions, or vision problems that could affect how they perform the trial's tests
People who have joint or bone diseases in their legs that affect their ability to move or walk
People who score below 21 out of 30 on a standard memory and thinking assessment called the Montreal Cognitive Assessment (MoCA)
People who have previously had surgery related to their Parkinson's disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kátia Monte-Silva, Universidade Federal de Pernambuco

Phone: 5581986450112

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06856941

Sponsor: Universidade Federal de Pernambuco

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 5581986450112

More information: https://clinicaltrials.gov/study/NCT06856941

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Parkinson's disease by a neurologist
People who have been taking dopaminergic medication (a common type of Parkinson's medication) regularly for at least three months
People who are 40 years of age or older
People whose Parkinson's symptoms fall within stages 1 to 4 on a standard scale used to measure how advanced the condition is (called the modified Hoehn and Yahr scale)

Who may not be able to join:

People who have other neurological conditions, low blood pressure when standing, balance-related ear problems, bone or muscle conditions, or vision problems that could affect how they perform the trial's tests
People who have joint or bone diseases in their legs that affect their ability to move or walk
People who score below 21 out of 30 on a standard memory and thinking assessment called the Montreal Cognitive Assessment (MoCA)
People who have previously had surgery related to their Parkinson's disease

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universidade Federal de Pernambuco

Registry

ClinicalTrials.gov

Start date

9 May 2024

Est. completion

1 July 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Timed Up and Go

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov